This is a news story, published by Australian Science Media Centre, that relates primarily to GLP-RA news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Australian Science Media Centre, you can click here:
more news from Australian Science Media CentreOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
diabetes drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest several cancers news, Associated Cancers news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pancreatic cancerAustralian Science Media Centre
•90% Informative
Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RA) may reduce the risk of obesity-related cancers more than other types of weight loss and diabetes drugs, according to international research.
The team investigated health record data on over a million people with type 2 diabetes who were either taking insulins, metformin or GLP-RA .
Those taking a GLP had a lower risk of being diagnosed with 10 of the cancers.
These include oesophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer.
VR Score
94
Informative language
97
Neutral language
79
Article tone
formal
Language
English
Language complexity
84
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
2
Source diversity
2
Affiliate links
no affiliate links